BELLUS Health Inc.

Company Profile

BELLUS Health Inc. had its IPO on 2008-12-29 under the ticker symbol BLU.

The company operates in the Healthcare sector and Biotechnology industry. BELLUS Health Inc. has a staff strength of 74 employees.

Stock update

Shares of BELLUS Health Inc. opened at $14.74 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $14.74 - $14.75, and closed at $14.74.

This is a 0% increase from the previous day's closing price.

A total volume of 3,449,256 shares were traded at the close of the day’s session.

In the last one week, shares of BELLUS Health Inc. have increased by +0.14%.

BELLUS Health Inc.'s Key Ratios

BELLUS Health Inc. has a market cap of $1.85 billion, indicating a price to book ratio of 3.0161 and a price to sales ratio of 75790.29.

In the last 12-months BELLUS Health Inc.’s revenue was $15000 with a gross profit of $16000 and an EBITDA of $-89987000. The EBITDA ratio measures BELLUS Health Inc.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, BELLUS Health Inc.’s operating margin was -602046.7% while its return on assets stood at -16.7% with a return of equity of -26.76%.

In Q1, BELLUS Health Inc.’s quarterly earnings growth was a positive 0% while revenue growth was a negative 25%.

BELLUS Health Inc.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.73 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BELLUS Health Inc.’s profitability.

BELLUS Health Inc. stock is trading at a EV to sales ratio of 53625.7024 and a EV to EBITDA ratio of -11.8482. Its price to sales ratio in the trailing 12-months stood at 75790.29.

BELLUS Health Inc. stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$379.54 million

Total Liabilities

$9.81 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

BELLUS Health Inc. ended 2024 with $379.54 million in total assets and $0 in total liabilities. Its intangible assets were valued at $379.54 million while shareholder equity stood at $368.90 million.

BELLUS Health Inc. ended 2024 with $0 in deferred long-term liabilities, $9.81 million in other current liabilities, in common stock, $-666898000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $85.38 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

BELLUS Health Inc.’s total current assets stands at $327.71 million while long-term investments were $0 and short-term investments were $227.61 million. Its net receivables were $990000.00 compared to accounts payable of $9.44 million and inventory worth $0.

In 2024, BELLUS Health Inc.'s operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, BELLUS Health Inc. paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$14.74

52-Week High

$14.67

52-Week Low

$6.38

Analyst Target Price

$15.68

BELLUS Health Inc. stock is currently trading at $14.74 per share. It touched a 52-week high of $14.67 and a 52-week low of $14.67. Analysts tracking the stock have a 12-month average target price of $15.68.

Its 50-day moving average was $14.55 and 200-day moving average was $10.13 The short ratio stood at 0.62 indicating a short percent outstanding of 0%.

Around 1026.1% of the company’s stock are held by insiders while 9040.9% are held by institutions.